Condition: Cirrhosis · HCC - Hepatocellular Carcinoma · Portal Vein Thrombosis · Sponsor: Mansoura University
We will give an anticoagulant against portal vein thrombosis, and watch for the results.
This description comes directly from the study's public registry record.
Dalia Elsayed Ganady, MBBS · +201095529264 · dalia.tawfik97@gmail.com
Hatem Elalfy, PhD · +201224790518 · elalfy2004@mans.edu.eg
Always discuss trial participation with your own doctor first.
| Mansoura University Hospitals | Al Mansurah, Dakahlia Governorate, Egypt | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07132515